Cargando…

Targeting the KIT Activating Switch Control Pocket: A Novel Mechanism to Inhibit Neoplastic Mast Cell Proliferation and Mast Cell Activation

Activating mutations in the receptor tyrosine kinase KIT, most notably KIT D816V, are commonly observed in patients with systemic mastocytosis. Thus, inhibition of KIT has been a major focus for treatment of this disorder. Here we investigated a novel approach to such inhibition. Utilizing rational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yun, Bandara, Geethani, Chan, Eunice Ching, Maric, Irina, Simakova, Olga, Bandara, Sachini N., Lu, Wei-Ping, Wise, Scott C., Flynn, Daniel L., Metcalfe, Dean D., Gilfillan, Alasdair M., Wilson, Todd M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529859/ https://www.ncbi.nlm.nih.gov/pubmed/22907049 http://dx.doi.org/10.1038/leu.2012.218

Ejemplares similares

Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT
por: Bandara, Geethani, et al.
Publicado: (2018)

Description and Characterization of a Novel Human Mast Cell Line for Scientific Study
por: S. Kirshenbaum, Arnold, et al.
Publicado: (2019)

Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production
por: Tobío, Araceli, et al.
Publicado: (2020)

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis
por: Bandara, Geethani, et al.
Publicado: (2023)

Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation
por: Obata, Yuuki, et al.
Publicado: (2014)

Aldh2 Attenuates Stem Cell Factor/Kit-Dependent Signaling and Activation in Mast Cells
por: Kim, Do-Kyun, et al.
Publicado: (2019)

Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle‐ and exosome‐like populations of KIT‐containing extracellular vesicles
por: Pfeiffer, Annika, et al.
Publicado: (2022)

Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis
por: Kirshenbaum, Arnold S., et al.
Publicado: (2016)

THE MORPHOLOGY AND BEHAVIOR OF NEOPLASTIC MAST CELLS CULTIVATED IN VITRO
por: Paff, George H., et al.
Publicado: (1947)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells
por: Hara, Yasushi, et al.
Publicado: (2017)

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2019)

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
por: Joris, Magalie, et al.
Publicado: (2012)

Mast cell activation syndrome
por: Ratner, Vicki
Publicado: (2015)

Mast Cell Activation Disorders
por: Giannetti, Arianna, et al.
Publicado: (2021)

Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases
por: Folkerts, Jelle, et al.
Publicado: (2018)

Human placental extract suppresses mast cell activation and induces mast cell apoptosis
por: Wu, Tongqian, et al.
Publicado: (2023)

The uptake of 5-hydroxytryptamine, histamine, and their amino acid precursors by neoplastic mast cells.
por: Green, J. P.
Publicado: (1966)

Galactosyl transferase of a Golgi fraction from cultured neoplastic mast cells
Publicado: (1977)

Mast cells rescue implantation defects caused by c-kit deficiency
por: Woidacki, K, et al.
Publicado: (2013)

ON THE ORIGIN OF HEPARIN : AN EXAMINATION OF THE HEPARIN CONTENT AND THE SPECIFIC CYTOPLASMIC PARTICLES OF NEOPLASTIC MAST CELLS
por: Oliver, Jean, et al.
Publicado: (1947)

ON THE ORIGIN OF HEPARIN : AN EXAMINATION OF THE HEPARIN CONTENT AND THE SPECIFIC CYTOPLASMIC PARTICLES OF NEOPLASTIC MAST CELLS
por: Oliver, Jean, et al.
Publicado: (1947)

RAPID CHANGES IN NUCLEOSIDE TRANSPORT INDUCED BY GROWTH INHIBITORS : Studies with Neoplastic Mast Cells
por: Lingwood, Clifford A., et al.
Publicado: (1974)

A Neoplastic Connective Tissue Mast Cell Capable of Continuous Growth In Tissue Culture
por: Williams, William J., et al.
Publicado: (1959)

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study
por: Russano de Paiva Silva, Geisilene, et al.
Publicado: (2018)

CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V(+) Neoplastic Mast Cells
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2022)

Cytological Quantification of Nodal Mast Cells in Dogs Affected by Non-Neoplastic Condition and Mast Cell Tumor Using Different Sample Preparation Techniques: An Explorative Study
por: Buzzi, Giulia, et al.
Publicado: (2023)

THE MAST CELLS
Publicado: (1960)

Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors
por: Webster, Joshua D, et al.
Publicado: (2006)

Mutations in C-KIT exon 11 in canine cutaneous mast cell tumors
por: Neto, Rafael T, et al.
Publicado: (2013)

Comparative aspects of mast cell neoplasia in animals and the role of KIT in prognosis and treatment
por: Tamlin, Vanessa S., et al.
Publicado: (2019)

Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function
por: Gudneppanavar, Ravindra, et al.
Publicado: (2023)

Activated mast cells produce interleukin 13
Publicado: (1995)

Utility of hydroxyurea in mast cell activation syndrome
por: Afrin, Lawrence B
Publicado: (2013)

Superantigenic Activation of Human Cardiac Mast Cells
por: Varricchi, Gilda, et al.
Publicado: (2019)

Recombinant ArtinM activates mast cells
por: Barbosa-Lorenzi, Valéria Cintra, et al.
Publicado: (2016)

Recent advances in mast cell activation and regulation
por: Kim, Hwan Soo, et al.
Publicado: (2020)

Local Mast Cell Activation Promotes Neovascularization
por: Bot, Ilze, et al.
Publicado: (2020)

Cellular Energetics of Mast Cell Development and Activation
por: Mendoza, Ryan P., et al.
Publicado: (2021)

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tdq1bqvegi21h26pkpk6oq9ojm